Matthew R Gardner (Matthew Gardner)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Men Who Have Sex With Men

Top Venues

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ashish Goyal, Matthew R Gardner, Bryan T Mayer, Keith R Jerome, Michael Farzan, Joshua T Schiffer, Erwing Fabian Cardozo Ojeda
Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission. Science advances 8 (2) (2022)
Meredith E Davis-Gardner, Barnett Alfant, Jesse A Weber, Matthew R Gardner, Michael Farzan
A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies. mBio 11 (1) (2020)
Matthew R Gardner, Christoph H Fellinger, Lisa M Kattenhorn, Meredith E Davis-Gardner, Jesse A Weber, Barnett Alfant, Amber S Zhou, Neha R Prasad, Hema R Kondur, Wendy A Newton, Kimberly L Weisgrau, Eva G Rakasz, Jeffrey D Lifson, Guangping Gao, Nancy J Schultz-Darken, Michael Farzan
AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges. Science translational medicine 11 (502) (2020)
Yuka Otsuka, Kimberly Schmitt, Brian D Quinlan, Matthew R Gardner, Barnett Alfant, Adrian Reich, Michael Farzan, Hyeryun Choe
Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies. PLoS pathogens 14 (8) (2018)
Meredith E Davis-Gardner, Matthew R Gardner, Barnett Alfant, Michael Farzan
eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients. PLoS pathogens 13 (12) (2017)